Immunolocalization of an amino-terminal fragment of apolipoprotein E in the Pick's disease brain

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Rohn, Troy T ^a   Day, Ryan J ^a   Catlin, Lindsey W ^a   Brown, Raquel J ^a   Rajic, Alexander J ^b   Poon, Wayne W ^b  

^a BOISE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E ANTIBODY; CASPASE; CELL PROTEIN; PROTEIN ANTIBODY; PROTEIN PHF 1; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; DENTATE GYRUS; FEMALE; HIPPOCAMPAL CA1 REGION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MALE; MIDDLE AGED; PATHOGENESIS; PICK PRESENILE DEMENTIA; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS;

APOLIPOPROTEINS E; CA1 REGION, HIPPOCAMPAL; DENTATE GYRUS; HUMANS; MALE; PICK DISEASE OF THE BRAIN;

EID: 84891786369     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080180     Document Type: Article

References (18)

1. Weisgraber KH, Rall SC, Jr., Mahley RW (1981) Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 256: 9077-9083.
2. Eisenstein M (2011) Genetics: finding risk factors. Nature 475: S20-22.
3. Wetterau JR, Aggerbeck LP, Rall SC, Jr., Weisgraber KH (1988) Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J Biol Chem 263: 6240-6248.
4. Rohn TT (2013) Proteolytic cleavage of apolipoprotein e4 as the keystone for the heightened risk associated with Alzheimer's disease. Int J Mol Sci 14: 14908-14922.
5. Harris FM, Brecht WJ, Xu Q, Tesseur I, Kekonius L, et al. (2003) Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurode-generation and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A 100: 10966-10971.
6. Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, et al. (2001) Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci U S A 98: 8838-8843.
7. Rohn TT, Catlin LW, Coonse KG, Habig JW (2012) Identification of an aminoterminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer's disease brain. Brain Res 1475: 106-115.
8. Uchihara T, Ikeda K, Tsuchiya K (2003) Pick body disease and Pick syndrome. Neuropathology 23: 318-326.
9. Hasegawa M (2006) Biochemistry and molecular biology of tauopathies. Neuropathology 26: 484-490.
10. Takeda N, Kishimoto Y, Yokota O (2012) Pick's disease. Adv Exp Med Biol 724: 300-316.
11. Feher A, Juhasz A, Rimanoczy A, Kalman J, Janka Z (2009) Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease. Alzheimer Dis Assoc Disord 23: 224-228.
12. Kalman J, Juhasz A, Majtenyi K, Rimanoczy A, Jakab K, et al. (2000) Apolipoprotein E polymorphism in Pick's disease and in Huntington's disease. Neurobiol Aging 21: 555-558.
13. Farrer LA, Abraham CR, Volicer L, Foley EJ, Kowall NW, et al. (1995) Allele epsilon 4 of apolipoprotein E shows a dose effect on age at onset of Pick disease. Exp Neurol 136: 162-170.
14. Wakabayashi K, Kakita A, Hayashi S, Okuizumi K, Onodera O, et al. (1998) Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease. Acta Neuropathol 95: 450-454.
15. Rohn TT, Kokoulina P (2009) Caspase-cleaved TAR DNA-binding protein-43 in Pick's disease. Int J Physio Pathophysio Pharmacol 1: 24-31.
16. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, et al. (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci U S A 100: 10032-10037.
17. Schneider A, Mandelkow E (2008) Tau-based treatment strategies in neurodegenerative diseases. Neurotherapeutics 5: 443-457.
18. Rohn TT, Catlin LW (2011) Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brain. PLoS One 6: e20495.